Literature DB >> 433668

Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. A comparative study between streptokinase and heparin therapy.

R Watz, G F Savidge.   

Abstract

The results of streptokinase and heparin treatment are compared in a 4-year prospective study with special reference to preservation of high valvular venous function. An objective assessment was based upon phlebographic examinations before, during and 1-2 months after therapy. Complete lysis was demonstrated in 44% of high thromboses treated with streptokinase and in 6% treated with heparin. Retrograde phlebography revealed normal function of the proximal femoral valves in 92% of streptokinase-treated high thromboses, compared with 13% of those treated with heparin. These phlebographic results were considered to be a valid prognostic indicator of the eventual development of the postthrombotic syndrome. Allergic reactions were seen in 39% and minor haemorrhagic complications in 18% of the streptokinase-treated cases. The therapeutic benefit of streptokinase therapy in this study was found to outweigh any disadvantages incurred by observed complications.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 433668     DOI: 10.1111/j.0954-6820.1979.tb06050.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  7 in total

1.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Deep vein thrombosis and pulmonary embolism: clinical presentation and pathophysiologic consequences.

Authors:  A J Comerota
Journal:  Cardiovasc Intervent Radiol       Date:  1988       Impact factor: 2.740

3.  Low-dose, once-daily, intraclot injections of alteplase for treatment of acute deep venous thrombosis.

Authors:  Richard Chang; McDonald K Horne; Thomas H Shawker; Anthony W Kam; Enn Alexandria Chen; Galen O Joe; Willie L Ching; Edie Mao; David A Wyrick; Jay N Lozier
Journal:  J Vasc Interv Radiol       Date:  2011-06-12       Impact factor: 3.464

4.  Mechanical interventions and thrombolytic therapy in venous thrombosis and pulmonary embolism.

Authors:  Rajesh Subramanian; Christopher J White
Journal:  Ochsner J       Date:  2002

5.  [Fibrinolytic therapy of lower limb deep vein thrombosis with urokinase (author's transl)].

Authors:  R Zimmermann; J Harenberg; H Mörl; H M Kuhn; P Wahl; P Gerhardt
Journal:  Klin Wochenschr       Date:  1982-05-17

6.  PHLECO: a multicenter study of the fate of 1647 hospital patients treated conservatively without fibrinolysis and surgery.

Authors:  M Martin
Journal:  Clin Investig       Date:  1993-06

7.  Long-term results of additional thrombolytic therapy in patients with acute deep vein thrombosis treated with pharmacomechanical thromboaspiration: A comparative study.

Authors:  Ali Aycan Kavala; Saygın Türkyılmaz
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-09-16       Impact factor: 0.332

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.